Hip Replacement Market Size and Forecast 2026–2034
According to Renub Research, the global hip replacement market is poised for steady expansion over the next decade. The market was valued at US$ 8.19 billion in 2025 and is projected to reach US$ 11.97 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.31% from 2026 to 2034.
The upward trajectory reflects a powerful combination of demographic shifts, technological innovation, and broader healthcare access. As populations age and musculoskeletal disorders become increasingly prevalent, hip replacement surgery is evolving from a specialized intervention to a mainstream orthopedic solution across both developed and emerging economies.
Download Free Sample Report:https://www.renub.com/request-sample-page.php?gturl=hip-replacement-market-global-forecast-p.php
Industry Overview: A Transformative Orthopedic Procedure
Hip replacement surgery, medically known as total hip arthroplasty, involves replacing a damaged or diseased hip joint with a prosthetic implant composed of metal, ceramic, or high-grade polyethylene components. The procedure is primarily performed to relieve chronic pain and restore mobility in patients suffering from:
-
Osteoarthritis
-
Rheumatoid arthritis
-
Post-traumatic arthritis
-
Hip fractures
-
Avascular necrosis
In a typical procedure, the damaged cartilage and bone are removed and replaced with an artificial ball-and-socket joint that mimics natural movement. Over the years, surgical precision, implant durability, and patient recovery timelines have improved significantly, making hip replacement one of the most successful and cost-effective orthopedic interventions globally.
Key Growth Drivers of the Hip Replacement Market
1. Aging Population and Rising Joint Disorders
The world is aging rapidly, and with age comes a higher likelihood of degenerative joint diseases. According to global health estimates, hundreds of millions of people suffer from osteoarthritis, with the majority being over 55 years old. Women represent a disproportionately higher percentage of affected individuals.
Older adults face cartilage degeneration, reduced bone density, and increased susceptibility to hip fractures — all of which contribute to rising surgical volumes. Countries in North America, Europe, Japan, and China are experiencing particularly sharp increases in their elderly populations, directly fueling procedural demand.
The demographic trend alone ensures a sustained baseline demand for hip replacement surgeries throughout the forecast period.
2. Technological Advancements in Implants and Surgical Techniques
Continuous technological innovation is reshaping the orthopedic landscape. Modern hip implants now feature advanced material combinations such as:
These materials significantly extend implant longevity, often lasting 15–20 years or more.
Minimally invasive surgical techniques, robotic-assisted systems, and computer-guided navigation have further improved precision and outcomes. Smaller incisions, reduced blood loss, and faster recovery times are increasing patient confidence and reducing hospitalization durations.
In October 2025, Zimmer Biomet received Breakthrough Device Designation from the U.S. FDA for its iodine-treated total hip replacement system — marking a milestone in infection prevention and implant safety innovation.
Such advancements are not only improving clinical outcomes but also expanding the eligible patient base, including younger and more active individuals.
3. Expanding Healthcare Access and Medical Tourism
Rising awareness about orthopedic treatments and improved healthcare infrastructure in emerging economies are driving procedural growth. Insurance penetration and government reimbursement programs have also made surgeries more accessible.
Medical tourism is another powerful growth lever. Countries like India are offering high-quality hip replacement procedures at significantly lower costs than Western nations. A unilateral hip replacement in India may cost around US$ 5,000 compared to US$ 25,000 or more in countries such as the United States, the United Kingdom, or Australia.
The Indian government’s “Heal in India” initiative is actively promoting the country as a global healthcare destination by improving visa processes, hospital infrastructure, and quality standards.
Market Challenges
High Surgical Costs
Despite being cost-effective over the long term, hip replacement surgery involves high upfront costs. Expenses include diagnostics, implant materials, surgical fees, hospital stays, and rehabilitation.
In low- and middle-income countries, limited insurance coverage makes affordability a key concern. Even in developed markets, rising healthcare expenditures can lead to delayed procedures.
Surgical Risks and Implant Longevity Concerns
Although generally safe, hip replacement carries potential risks:
Younger, more active patients may experience earlier implant wear, increasing revision surgery rates. Concerns about complications can delay surgical decisions, particularly in regions lacking robust post-operative care systems.
Market Segmentation Analysis
By Product
Total Hip Replacement (THR)
Total hip replacement dominates the global market due to its effectiveness in severe degenerative conditions. Both the femoral head and acetabulum are replaced, providing long-term pain relief and mobility restoration.
Its high success rate and prosthetic longevity make it the preferred choice for advanced osteoarthritis and rheumatoid arthritis cases.
Partial Hip Replacement
Partial procedures replace only the femoral head while preserving the natural socket. These are typically performed in elderly patients with specific fracture types.
Benefits include shorter operation time, reduced blood loss, and quicker recovery. However, its applicability is narrower than total replacement, limiting overall market share.
Revision Hip Replacement
Revision surgeries address implant failure, wear, or complications from earlier procedures. As primary surgeries increase globally, revision volumes are expected to rise correspondingly, creating a secondary growth avenue.
By End-User
Hospitals & Surgery Centers
Hospitals and specialized surgery centers account for the largest market share due to advanced infrastructure and ability to handle complex cases. Robotic-assisted and minimally invasive procedures are primarily concentrated in these facilities.
Ambulatory surgery centers are gaining popularity due to shorter stays and cost efficiency.
Orthopaedic Clinics
Orthopedic clinics are playing an increasingly vital role in early diagnosis, patient education, surgical planning, and rehabilitation. As healthcare decentralizes, clinics are becoming important nodes in the orthopedic ecosystem.
Regional Insights
United States
The United States remains one of the most mature and technologically advanced hip replacement markets. High awareness, favorable reimbursement policies, and access to leading orthopedic specialists sustain demand.
Technological leadership continues to define the U.S. landscape, with advanced robotic and minimally invasive techniques becoming mainstream.
United Kingdom
The United Kingdom benefits from a structured public healthcare system that facilitates access to orthopedic surgery. While waiting times can affect volumes, investments in surgical efficiency and private healthcare expansion support stable market growth.
India
India is emerging as one of the fastest-growing hip replacement markets globally. Rising arthritis incidence, road injuries, and longer life expectancy are driving demand.
In January 2026, Manipal Hospital Gurugram successfully performed a 3D-navigated total hip replacement using advanced navigation systems, highlighting India’s rapid adoption of modern surgical technologies.
Cost efficiency, skilled surgeons, and strong medical tourism inflows make India a strategic growth hub.
Saudi Arabia
Saudi Arabia’s healthcare modernization initiatives are strengthening domestic orthopedic capabilities. Rising obesity rates and aging demographics contribute to demand.
In January 2026, orthopedic specialists at Dallah Al Nakheel Hospital successfully conducted hip replacement surgery using the Direct Anterior Approach (DAA), enabling faster recovery and minimal muscle disruption — a testament to the region’s growing surgical sophistication.
Competitive Landscape
The global hip replacement market is moderately consolidated, with key players competing through innovation, geographic expansion, and strategic partnerships.
Major companies profiled include:
These companies are investing heavily in R&D, robotic-assisted platforms, infection-resistant implants, and patient-specific prosthetics.
Country Coverage
North America: United States, Canada
Europe: France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey
Asia Pacific: China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand
Latin America: Brazil, Mexico, Argentina
Middle East & Africa: South Africa, Saudi Arabia, United Arab Emirates
Final Thoughts
The hip replacement market is entering a decade of measured but resilient growth. With a projected rise from US$ 8.19 billion in 2025 to US$ 11.97 billion by 2034, the industry reflects the intersection of demographic inevitability and medical innovation.
Aging populations, increasing osteoarthritis prevalence, and technological breakthroughs in implant design and robotic surgery are forming a durable foundation for expansion. At the same time, challenges related to affordability and surgical risk underscore the importance of policy support and clinical advancement.
As healthcare systems modernize and patient awareness increases, hip replacement surgery will continue to transform lives — restoring mobility, reducing pain, and improving quality of life for millions worldwide.
